Human exposure to parabens as a preservative used in personal care products is of increasing concern, as there is evidence from in vivo and in vitro studies of hormone disruption in association with exposure to parabens. Transport across the placenta could be critical for risk assessment, but the available data are sparse. The aim is to develop a method for estimating fetal exposure, via the placenta, to the most commonly-used parabens, by using a human placental perfusion model. The use of human tissue is vital for determining human fetal exposure, because animal studies are of little relevance, since the placenta exhibits significant interspecies variation. An HPLC model is currently being established to simultaneously quantify four different parabens, namely, methylparaben, ethylparaben, propylparaben and butylparaben, and their main metabolite, p-hydroxybenzoic acid. With this model, we aim to determine the transport kinetics of these parabens across the human placenta, and to investigate placental metabolism, including differences in transport due to molecular characteristics. This will facilitate assessment of the risks associated with the use of paraben-containing products during pregnancy.
LiaoC., ChenL. & KannanK. (2013). Occurrence of parabens in foodstuffs from China and its implications for human dietary exposure. Environment International 57–58, 68–74.
2.
AndersenF.A. (2008). Final amended report on the safety assessment of methylparaben, ethylparaben, propylparaben, isopropylparaben, butylparaben, isobutylparaben, and benzylparaben as used in cosmetic products. International Journal of Toxicology27, 1–82.
3.
BruiceY.P. (2012). Organic Chemistry, 7th edn, 1392pp. Upper Saddle River, NJ, USA: Prentice Hall, Inc.
4.
SoniM.G., CarabinI.G. & BurdockG.A. (2005). Safety assessment of esters of p-hydroxybenzoic acid (parabens). Food & Chemical Toxicology43, 985–1015.
BaisH.P., VepacheduR. & VivancoJ.M. (2003). Root specific elicitation and exudation of fluorescent β-carbolines in transformed root cultures of Oxalis tuberosa. Plant Physiology & Biochemistry41, 345–353.
7.
JanjuaN.R., MortensenG.K., AnderssonA.M., KongshojB., SkakkebaekN.E. & WulfH.C. (2007). Systemic uptake of diethyl phthalate, dibutyl phthalate, and butyl paraben following whole-body topical application and reproductive and thyroid hormone levels in humans. Environmental Science & Technology41, 5564–5570.
8.
MeekerJ.D., YangT., YeX., CalafatA.M. & HauserR. (2011). Urinary concentrations of parabens and serum hormone levels, semen quality parameters, and sperm DNA damage. Environmental Health Perspectives119, 252–257.
BandoH., MohriS., YamashitaF., TakakuraY. & HashidaM. (1997). Effects of skin metabolism on percutaneous penetration of lipophilic drugs. Journal of Pharmaceutical Science, New York86, 759–761.
11.
RoutledgeE.J., ParkerJ., OdumJ., AshbyJ. & SumpterJ. (1998). Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic. Toxicology & Applied Pharmacology153, 12–19.
12.
Dal PozzoA. & PastoriN. (1996). Percutaneous absorption of parabens from cosmetic formulations. International Journal of Cosmetic Science18, 55–66.
13.
United States Environmental Protection Agency (2011). Exposure Factors Handbook: 2011 Edition, EPA/600/R-090/052F, 1436pp. Washington, DC, USA: National Center for Environmental Assessment. Available at: http://www.epa.gov/ncea/efh/pdfs/efh-complete.pdf (Accessed 09.12.13).
14.
DarbreP.D. & HarveyP.W. (2008). Paraben esters: Review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks. Journal of Applied Toxicology28, 561–578.
15.
Anon. (1976). Council Directive of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products (76/768/EEC). Official Journal of the European Communities L262, 27.9.1976, 169–200.
16.
EFSA (2004). Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food on a Request from the Commission Related to Para Hydroxybenzoates (E 214-219), 26pp. Parma, Italy: European Food Safety Authority. Available at: http://www.efsa.europa.eu/en/efsajournal/pub/83.htm (Accessed 09.12.13).
17.
SchuebelK. (1930). Toxicology of new preservatives: p-Chlorobenzoic acid and p-hydroxybenzoic acid esters. Muenchener Medizinische Wochenschrift77, 13–14.
18.
MatthewsC., DavidsonJ., BauerE., MorrisonJ.L. & RichardsonA.P. (1956). p-Hydroxybenzoic acid esters as preservatives II. Acute and chronic toxicity in dogs, rats and mice. Journal of the American Pharmaceutical Association (Scientific edn)45, 260–267.
19.
KangS., KimS., ParkJ., KimH.J., LeeJ., ChoiG., ChoiS., KimS., KimS.Y., MoonH.B., KimS., KhoY.L. & ChoiK. (2013). Urinary paraben concentrations among pregnant women and their matching newborn infants of Korea, and the association with oxidative stress biomarkers. Science of the Total Environment 461–462, 214–221.
20.
McGrathK.G. (2003). An earlier age of breast cancer diagnosis related to more frequent use of antiperspirants/deodorants and underarm shaving. European Journal of Cancer Prevention12, 479–485.
21.
MirickD.K., DavisS. & ThomasD.B. (2002). Antiperspirant use and the risk of breast cancer. Journal of the National Cancer Institute94, 1578–1580.
22.
SokolH. (1952). Recent developments in the preservation of pharmaceuticals. Drug Standards20, 89–106.
23.
MarzulliF.N. & MaibachH.I. (1973). Antimicrobials: Experimental contact sensitization in man. Journal of the Society of Cosmetic Chemists24, 399–421.
24.
NagelJ.E., FuscaldoJ.T. & FiremanP. (1977). Paraben allergy. Journal of the American Medical Association237, 1594–1595.
25.
Scientific Committee on Consumer Safety (2011). Clarification on Opinion SCCS/1348/10 in the light of the Danish clause of safeguard banning the use of parabens in cosmetic products intended for children under three years of age [SCCS/1446/11], 51pp. Brussels, Belgium: European Commission, Directorate General for Health & Consumers.
26.
JorgensenN., JoensenU.N., JensenT.K., JensenM.B., AlmstrupK., OlesenI.A., JuulA., AnderssonA.M., CarlsenE., PetersenJ.H., ToppariJ. & SkakkebaekN.E. (2012). Human semen quality in the new millennium: A prospective cross-sectional population-based study of 4867 men. BMJ Open2, e000990 doi:10.1136/bmjopen-2012-000990.
DarbreP.D., AljarrahA., MillerW.R., ColdhamN.G., SauerM.J. & PopeG.S. (2004). Concentrations of parabens in human breast tumours. Journal of Applied Toxicology24, 5–13.
29.
BeckF. (1976). Comparative placental morphology and function. Environmental Health Perspectives18, 5–12.
30.
WolfgangM.J., EiseleS.G., BrowneM.A., SchotzkoM.L., GarthwaiteM.A., DurningM., RamezaniA., HawleyR.G., ThomsonJ.A. & GolosT.G. (2001). Rhesus monkey placental transgene expression after lentiviral gene transfer into preimplantation embryos. Proceedings of the National Academy of Sciences of the USA98, 10, 728–10, 732.
31.
BarryJ.S. & AnthonyR.V. (2008). The pregnant sheep as a model for human pregnancy. Theriogenology69, 55–67.
32.
KnudsenL.E. (2013). Animal-free toxicology: The use of human tissue to replace the use of animals — Examples from human biomonitoring and human placental transport studies. ATLA41, 443–447.
MyllynenP., MathiesenL., WeimerM., AnnolaK., ImmonenE., KarttunenV., KummuM., MørckT.J., NielsenJ.K., KnudsenL.E. & VähäkangasK. (2010). Preliminary interlaboratory comparison of the ex vivo dual human placental perfusion system. Reproductive Toxicology30, 94–102.
35.
MoseT., KnudsenL.E., HedegaardM. & MortensenG.K. (2007). Transplacental transfer of monomethyl phthalate and mono(2-ethylhexyl) phthalate in a human placenta perfusion system. International Journal of Toxicology26, 221–229.
36.
FrederiksenM., VorkampK., MathiesenL., MoseT. & KnudsenL.E. (2010). Placental transfer of the polybrominated diphenyl ethers BDE-47, BDE-99 and BDE-209 in a human placenta perfusion system: An experimental study. Environmental Health9, 32–41.
37.
Correia CarreiraS., CartwrightL., MathiesenL., KnudsenL.E. & SaundersM. (2011). Studying placental transfer of highly purified non-dioxin-like PCBs in two models of the placental barrier. Placenta32, 283–291.
38.
MathiesenL., RyttingE., MoseT. & KnudsenL.E. (2009). Transport of benzo[alpha]pyrene in the dually perfused human placenta perfusion model: Effect of albumin in the perfusion medium. Basic Clinical Pharmacology & Toxicology105, 181–187.
39.
Vela-SoriaF., Jimenez-DiazI., Rodriguez-GomezR., Zafra-GomezA., BallesterosO., FernandezM.F., OleaN. & NavalonA. (2011). A multiclass method for endocrine disrupting chemical residue analysis in human placental tissue samples by UHPLC-MS/MS. Analytical Methods3, 2073–2081.
40.
MoseT. & KnudsenL.E. (2006). Placental perfusion — a human alternative. ALTEX23, Suppl., 358–363.
41.
BremerS., BritteboE., DenckerL., KnudsenL.E., MathiesenL., OlovssonM., PazosP., PellizzerC., PaulesuL.R., SchaeferW., SchwarzM., StaudF., Stavreus-EversA. & VähänkangasK. (2007). In vitro tests for detecting chemicals affecting the embryo implantation process. The report and recommendations of ECVAM workshop 62 — A strategic workshop of the EU ReProTect project. ATLA35, 421–439.
42.
MoseT., KjaerstadM.B., MathiesenL., NielsenJ.B., EdelforsS. & KnudsenL.E. (2008). Placental passage of benzoic acid, caffeine, and glyphosate in an ex vivo human perfusion system. Journal of Toxicology & Environmental Health A71, 984–991.
43.
MorckT.J., SordaG., BechiN., RasmussenB.S., NielsenJ.B., IettaF., RyttingE., MathiesenL., PaulesuL. & KnudsenL.E. (2010). Placental transport and in vitro effects of bisphenol A. Reproductive Toxicology30, 131–137.
44.
PanigelM. (1985). Past, present, and future of placental perfusion experiments. Contributions to Gynecology & Obstetrics13, 132–136.
45.
SchneiderH., SodhaR.J., ProglerM. & YoungM.P. (1985). Permeability of the human placenta for hydrophilic substances studied in the isolated dually in vitro perfused lobe. Contributions to Gynecology & Obstetrics13, 98–103.
46.
MoseT., MathiesenL., KarttunenV., NielsenJ.K.S., SieppiE., KummuM., MørckT.A., MyöhänenK., PartanenH., VähäkangasK., KnudsenL.E. & MyllynenP. (2012). Meta-analysis of data from human ex-vivo placental perfusion studies on genotoxic and immunotoxic agents within the integrated European project NewGeneris. Placenta33, 433–439.
US EPA (2013). Estimation Programs Interface Suite™ for Microsoft® Windows (EPI Suite), Version 4.11. Washington, DC, USA: United States Environmental Protection Agency.
49.
ShiraiS., SuzukiY., YoshinagaJ., ShiraishiH. & MizumotoY. (2013). Urinary excretion of parabens in pregnant Japanese women. Reproductive Toxicology35, 96–101.
50.
CasasL., FernandezM.F., LlopS., GuxensM., BallesterF., OleaN., IrurzunM.B., RodriguezL.S., RianoI., TardonA., VrijheidM., CalafatA.M., SunyerJ.; INMA Project (2011). Urinary concentrations of phtalates and phenols in a population of Spanish pregnant women and children. Environment International37, 858–866.
51.
PhilippatC., MortamaisM., ChevrierC., PetitC., CalafatA.M., YeX., SilvaM.J., BrambillaC., PinI., CharlesM.A., CordierS. & SlamaR. (2012). Exposure to phthalates and phenols during pregnancy and offspring size at birth. Environmental Health Perspectives120, 464–470.
52.
SmithK.W., BraunJ.M., WilliamsP.L., EhrlichS., CorreiaK.F., CalafatA.M., YeX., FordJ., KellerM., MeekerJ.D. & HauserR. (2012). Predictors and variability of urinary paraben concentrations in men and women, including before and during pregnancy. Environmental Health Perspectives120, 1538–1543.
53.
FrederiksenH., JørgensenN. & AnderssonA.M. (2011). Parabens in urine, serum and seminal plasma from healthy Danish men determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Journal of Exposure Science & Environmental Epidemiology21, 262–271.
